Free provider profile

RENEE PRINS, M.D.

NPI 1639381346
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like RENEE PRINS?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What RENEE PRINS prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Venclexta
  • Jakafi
  • Kisqali
  • Brukinsa
  • Xtandi

See all hematologist-oncologists in OR who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

503-561-6444

Practice address

875 OAK ST SE STE 4030, SALEM, OR, 97301

Registry updated
2023-06-08
NPI issued
2007-05-04
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

875 OAK ST SE STE 4030, SALEM, OR, 97301

503-561-6444

Single practice location

Enumerated 2007-05-04

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — 2 taxonomies listed — broader service mix.
  • — Record last updated 3 years ago.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

2,503

Medicare patients

277

Part D drug cost

$3,627,027

Brand-name share

19.4%

of this prescriber's Part D claims

DrugClaimsMedicare cost
Jakafi (Ruxolitinib Phosphate)23$362,587
Brukinsa (Zanubrutinib)21$309,002
Venclexta (Venetoclax)30$281,847
Xtandi (Enzalutamide)19$265,289
Kisqali (Ribociclib Succinate)23$264,146
Pomalyst (Pomalidomide)12$257,345
Ibrance (Palbociclib)14$215,987
Imbruvica (Ibrutinib)13$214,930

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across OR — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.